Patents by Inventor Stuart Johnson
Stuart Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20030204775Abstract: A modified transaction registration protocol is disclosed. The registration protocol is inherently centralized in that processes requesting registration to participate in the work of a transaction, must send a request to a Broadcast Owner CPU which is the CPU that initiated the transaction. The processes wait, suspended, until a response is received from the Broadcast Owner CPU. However, if the Broadcast Owner CPU fails to respond to the registration request, then the processes that are waiting are incapable performing work for the transaction. While a CPU failure may not occur often, in a fault-tolerant system, such events must be accounted for. Therefore, the transaction registration protocol is modified to revert to a Full Broadcast transaction protocol and complete any outstanding registration requests. This is accomplished by distributing transactions to all of the CPUs in the system, and in each CPU forcing the completion of registration requests in each CPU.Type: ApplicationFiled: November 21, 2002Publication date: October 30, 2003Inventors: Trina R. Wisler, Jim B. Tate, David C. Hege, Charles Stuart Johnson, David J. Wisler
-
Patent number: 6553519Abstract: Method and apparatus for detecting signal transfer errors in a digital logic system that might occur in a transfer medium between a source device and a destination device. The method includes sending a first diagnostic signal of one or more bits from the source device through the transfer medium to the destination device; comparing the first diagnostic signal received by the destination device with a second diagnostic signal within the destination device to determine if a signal transfer error has occurred; inverting the first diagnostic signal; sending the inverted first diagnostic signal from the source device through the transfer medium to the destination device; and comparing the inverted first diagnostic signal received by the destination device with the second diagnostic signal to determine if a signal transfer error has occurred. Two embodiments of the invention are disclosed.Type: GrantFiled: October 5, 1998Date of Patent: April 22, 2003Assignee: Alcatel Internetworking (PE), Inc.Inventors: Jeffrey J. Walker, Greg W. Davis, C Stuart Johnson
-
Publication number: 20030074522Abstract: A method to record information on a data storage medium using buffered tape marks. A data storage device comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. Computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or other non-volatile memory device disposed in a host computer, a data storage device, and/or a library controller.Type: ApplicationFiled: October 15, 2001Publication date: April 17, 2003Inventors: Kirby Grant Dahman, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Wayne Erwin Rhoten
-
Publication number: 20030065881Abstract: A method to record information on a data storage medium using buffered tape marks. A data storage device comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. Computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or other non-volatile memory device disposed in a host computer, a data storage device, and/or a library controller.Type: ApplicationFiled: October 1, 2001Publication date: April 3, 2003Inventors: Kirby Grant Dahman, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Wayne Erwin Rhoten
-
Publication number: 20030065667Abstract: A method for fast multiple file write operations using a deferred conditional a write tape mark command and a deferred conditional tape mark indicator. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method for fast multiple file write operations. A data management system comprising computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or another non-volatile memory device, disposed in a host computer and/or a data storage and retrieval system.Type: ApplicationFiled: October 1, 2001Publication date: April 3, 2003Inventors: Kirby Grant Dahman, Erika Marianna Dawson, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, James Mitchell Ratliff, Wayne Erwin Rhoten
-
Publication number: 20030065903Abstract: A storage management system, apparatus, and method to increase the storage capacity of data storage media. Applicants' method uses a data storage device comprising a fixed device architecture, where that data storage device is capable of operating in a first capacity mode or in a second capacity mode, and where that data storage device is capable of switching between the first capacity mode and the second capacity mode. In certain embodiments, the first capacity mode utilizes a 22 bit blockid format and the second capacity mode utilizes a 32 bit blockid format. In other embodiments, the first capacity mode utilizes a 32 bit blockid format and the second capacity mode utilizes a 22 bit blockid format.Type: ApplicationFiled: October 1, 2001Publication date: April 3, 2003Inventors: Lyn Lequam Ashton, Kirby Grant Dahman, Erika Marianna Dawson, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Michael Ray Noel, James Mitchell Ratliff, Anthony Steve Pearson, Wayne Erwin Rhoten
-
Patent number: 6492160Abstract: Methods, recombinant host cells and kits are disclosed-for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.Type: GrantFiled: June 25, 1998Date of Patent: December 10, 2002Assignees: Cambridge Antibody Technology Limited, Medical Research CouncilInventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith
-
Patent number: 6489123Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyze binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.Type: GrantFiled: January 23, 2001Date of Patent: December 3, 2002Assignee: Cambridge Antibody Technology LimitedInventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
-
Patent number: 6342588Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.Type: GrantFiled: August 16, 1999Date of Patent: January 29, 2002Assignee: Cambridge Antibody Technology LimitedInventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
-
Publication number: 20020004215Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyze binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.Type: ApplicationFiled: January 23, 2001Publication date: January 10, 2002Applicant: Cambridge Antibody Technology, Ltd.Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
-
Patent number: 6291650Abstract: The invention provides methods and kits for producing specific binding pairs (sbp) members. Populations of polypeptide chain components of sbp members are combined to form libraries of sbps displayed by secreted replicable genetic display packages (rgdp). At least one of the polypeptide chains is expressed as a fusion with a component of an rgdp which thereby displays that polypeptide chain at the surface of rgdp. At least one population of polypeptide chains is expressed from nucleic acid which is capable of being packaged using a component of an rgdp, whereby the genetic material of rgdps produced encodes a polypeptide chain. The methods enable production of libraries of multimeric sbp members from a very large number of possible combinations. In one embodiment of the invention a method employs “chain shuffling” in the production of sbp members of desired specificity for a counterpart sbp member. Selection procedures are also described.Type: GrantFiled: June 25, 1998Date of Patent: September 18, 2001Assignees: Cambridge Antibody Technology, Ltd., Medical Research CouncilInventors: Gregory Paul Winter, Kevin Stuart Johnson, Andrew David Griffiths, Andrew John Hammond Smith
-
Patent number: 6225447Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a fist and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.Type: GrantFiled: June 17, 1998Date of Patent: May 1, 2001Assignees: Cambridge Antibody Technology Ltd., Medical Research CouncilInventors: Gregory Paul Winter, Kevin Stuart Johnson, Andrew David Griffiths, Andrew John Hammond Smith
-
Patent number: 6180336Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.Type: GrantFiled: June 17, 1998Date of Patent: January 30, 2001Assignee: Cambridge Antibody Technology LimitedInventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
-
Patent number: 6172197Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA.Type: GrantFiled: June 7, 1995Date of Patent: January 9, 2001Assignees: Medical Research Council, Cambridge Antibody Technology LimitedInventors: John McCafferty, Anthony Richard Pope, Kevin Stuart Johnson, Henricus Renerus Jacobus Mattheus Hoogenboom, Andrew David Griffiths, Ronald Henry Jackson, Kaspar Philipp Holliger, James David Marks, Timothy Piers Clackson, David John Chiswell, Gregory Paul Winter, Timothy Peter Bonnert
-
Patent number: 6140471Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.Type: GrantFiled: March 30, 1998Date of Patent: October 31, 2000Assignees: Cambridge Antibody Technology, Ltd., Medical Research CouncilInventors: Kevin Stuart Johnson, Gregory Paul Winter, Andrew David Griffiths, Andrew John Hammond Smith, Peter Michael Waterhouse
-
Patent number: 5994519Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.Type: GrantFiled: July 8, 1997Date of Patent: November 30, 1999Assignee: Cambridge Antibody Technology LimitedInventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
-
Patent number: 5980907Abstract: Attenuated microorganism for use in immunoprophylaxis in which the attenuation is brought about by the presence of a mutation in the DNA sequence of the microorganism which encodes, or which regulates the expression of DNA encoding a protein that is produced in response to environmental stress, the microorganism optionally being capable of expressing DNA encoding a heterologous antigen.Type: GrantFiled: June 5, 1995Date of Patent: November 9, 1999Assignee: Glaxo Wellcome Inc.Inventors: Gordan Dougan, Ian George Charles, Carlos Estenio Hormaeche, Kevin Stuart Johnson, Steven Neville Chatfield
-
Patent number: 5977319Abstract: The invention relates to specific binding members for estradiol and materials and methods relating thereto, in particular antibodies or binding domains thereof which have high affinities (low dissociation constants) for estradiol and low cross-reactivity for other steroids. The invention further provides means to make such binding members, assay methods for the detection and/or quantitation of estradiol, and nucleic acid encoding said binding members, which nucleic acid may be used for their production. Preferred binding members include those with CDR regions of the D12 antibody heavy and light chain domains (SEQ ID NO:2 and SEQ ID NO:12 respectively).Type: GrantFiled: October 21, 1997Date of Patent: November 2, 1999Assignee: Cambridge Antibody Technology LimitedInventors: Anthony Richard Pope, Kevin Pritchard, Andrew James Williams, Kevin Stuart Johnson
-
Patent number: 5969108Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA.Type: GrantFiled: January 8, 1993Date of Patent: October 19, 1999Assignees: Medical Research Council, Cambridge Antibody Technology LimitedInventors: John McCafferty, Anthony Richard Pope, Kevin Stuart Johnson, Henricus Renerus Jacobus Mattheus Hoogenboom, Andrew David Griffiths, Ronald Henry Jackson, Kaspar Philipp Holliger, James David Marks, Timothy Piers Clackson, David John Chiswell, Gregory Paul Winter, Timothy Peter Bonnert
-
Patent number: 5962255Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.Type: GrantFiled: December 5, 1994Date of Patent: October 5, 1999Assignees: Cambridge Antibody Technology Limited, Medical Research CouncilInventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith